The compound at the center of the dispute is semaglutide, a GLP-1 receptor agonist that helps regulate blood sugar and appetite
However, if you notice signs like redness with warmth, pus, fever, or severe pain, its time to call your healthcare provider
If using a vial : Wipe the rubber stopper with an alcohol swab
If you are struggling with weight management or glucose control, your GP can assess whether you meet criteria for NHS-funded GLP-1 receptor agonist therapy under relevant NICE technology appraisals (such as TA875 for semaglutide or TA664 for liraglutide for weight management), which is considerably more effective than any natural supplement
The answer is yes for most TRICARE plans, but there are important details to understand, especially after the policy changes that took effect in August 2025
Based on the platforms published programme details each order contains: Compounded GLP-1 vial either semaglutide or tirzepatide depending on your prescription Injection supplies including syringes and alcohol swabs for self-administration Dosing instructions with written guidance on how to measure and inject your dose correctly Patient portal access for secure messaging with your assigned provider on dosage questions and adjustments Free mobile app for order tracking, refill management and provider communication Itemised receipt generated automatically for HSA or FSA reimbursement submission Injections are administered once a week
